What do antineutrophil cytoplasmic antibodies (ANCA) tell us?

被引:48
|
作者
Savige, J [1 ]
Pollock, W [1 ]
Trevisin, M [1 ]
机构
[1] Univ Melbourne, No Gen Hosp, Dept Med, Austin Hlth No Hlth, Epping, Vic 3076, Australia
来源
关键词
small-vessel vasculitis; Wegener's granulomatosis; microscopic polyangiitis; antineutrophil cytoplasmic antibodies (ANCA); neutrophil-specific antibodies; direct ELISA; capture ELISA; indirect immunofluorescence; proteinase; 3; myeloperoxidase;
D O I
10.1016/j.berh.2004.10.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antineutrophil cytoplasmic antibodies (ANCA) are autoantibodies directed against antigens found in the cytoplasmic granules of neutrophils and monocytes. ANCA testing is usually performed to help diagnose or exclude Wegener's granulomatosis and microscopic polyangiitis. The three most commonly used assays are indirect immunofluorescence (IIF) and the direct and 'capture' enzyme-linked immunosorbent assays (ELISAs) for ANCA directed against proteinase 3 (PR3) and myeloperoxidase (MPO). Although the International Consensus Statement for Testing and Reporting ANCA recommends that all sera are screened for ANCA by IIF and that IIF-positivity is confirmed by direct ELISAs, some laboratories test by direct ELISA alone, others screen with direct ELISA and confirm positive sera by IIF, and a few use capture ELISAs. This chapter discusses the various forms of vasculitis associated with ANCA, the usefulness of each of the ANCA assays and how ANCA testing can be used in the management of patients with small-vessel vasculitis.
引用
收藏
页码:263 / 276
页数:14
相关论文
共 50 条
  • [21] WHEN AND WHY CHECK FOR ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN DERMATOLOGY
    DELAPORTE, E
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1995, 122 (08): : 558 - 559
  • [22] ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) AND INFLAMMATORY BOWEL DISEASES IN CHINESE
    SUNG, JY
    CHAN, FKL
    LAWTON, J
    LEUNG, JCK
    LIEW, CT
    LEUNG, NWY
    HSU, R
    LAI, KN
    DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (04) : 886 - 892
  • [23] DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) USING THE IMMUNOPEROXIDASE METHOD
    INAMURA, K
    FUKASE, S
    OHTA, N
    SAKATA, K
    KOIKE, Y
    ACTA OTO-LARYNGOLOGICA, 1994, : 218 - 220
  • [25] DIAGNOSTIC SPECIFICITY OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) IN OTORHINOLARYNGOLOGICAL DISEASES
    FUKASE, S
    OHTA, N
    INAMURA, K
    KIMURA, Y
    AOYAGI, M
    KOIKE, Y
    ACTA OTO-LARYNGOLOGICA, 1994, : 204 - 207
  • [26] The antineutrophil cytoplasmic antibodies (ANCA typical or not) in current medical practice
    Renaudineau, Y.
    Beauvillard, D.
    Segalen, I.
    Leroyer, C.
    Le Meur, Y.
    Youinou, P.
    IMMUNO-ANALYSE & BIOLOGIE SPECIALISEE, 2011, 26 (01): : 27 - 34
  • [27] The target antigens of antineutrophil cytoplasmic antibodies (ANCA) induced by propylthiouracil
    Gao, Ying
    Chen, Min
    Ye, Hua
    Guo, Xiao-Hui
    Zhao, Ming-hui
    Wang, Hai-yan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (01) : 55 - 60
  • [28] ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA) - THEIR ROLE IN DIAGNOSIS AND PATHOGENESIS OF VASCULITIS
    FIELD, M
    BRITISH JOURNAL OF RHEUMATOLOGY, 1991, 30 (03): : 229 - 231
  • [29] DIAGNOSTIC-SIGNIFICANCE OF THE DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA)
    HADJIYANNAKOS, D
    TERZOGLOU, K
    ECONOMOU, M
    NIKOLOPOULOU, N
    MARAGOU, M
    STAVROPOULOS, P
    RODOUSSAKI, Z
    ATHANASIADOU, S
    DANTIS, P
    BILLIS, A
    KIDNEY INTERNATIONAL, 1993, 44 (04) : 906 - 906
  • [30] Maintenance treatment for antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitides
    Guillevin, L.
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (01): : 48 - 52